Literature DB >> 26228931

Characterization of repolarization in Brugada syndrome patients during exercise testing: Dynamic angle evaluation.

Thomas Pospiech1, Jérémie Jaussaud2, Frédéric Sacher3, Darren A Hooks4, Michel Haïssaguerre3, Hervé Douard5.   

Abstract

BACKGROUND: A new ECG criterion has been studied in Brugada syndrome (BrS) at rest to differentiate type 2 and incomplete right bundle branch block (IRBBB).
METHODS: We assessed this criterion during exercise comparing BrS (46 patients) and IRBBB (17 patients). A beta angle was measured from lead V1 between the upslope of S-wave and the downslope of the r'-wave.
RESULTS: Beta angle was significantly larger in BrS at rest (58±24° vs 25±15°, p<0.001), exercise (47±26° vs 15±11°, p<0.001), and recovery (46±24° vs 21±12°, p<0.001) with a reduction in angle at exercise compared to rest. There was a significant rebound in angle at recovery in the control group to (p<0.001); no such rebound was observed in the BrS group (p=NS).
CONCLUSION: Beta angle study at rest and its evolution at exercise could help discriminate BrS patients from healthy subjects.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brugada syndrome; Exercise testing; Incomplete RBBB; Repolarization

Mesh:

Year:  2015        PMID: 26228931     DOI: 10.1016/j.jelectrocard.2015.06.008

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  2 in total

1.  Does difference in ICD indication result in a difference in inappropriate shock risk?

Authors:  J William Schleifer; Samuel J Asirvatham
Journal:  Indian Pacing Electrophysiol J       Date:  2016-12-28

2.  Significance of Exercise-Related Ventricular Arrhythmias in Patients With Brugada Syndrome.

Authors:  Hiroshi Morita; Saori T Asada; Masakazu Miyamoto; Yoshimasa Morimoto; Tomonari Kimura; Tomofumi Mizuno; Koji Nakagawa; Atsuyuki Watanabe; Nobuhiro Nishii; Hiroshi Ito
Journal:  J Am Heart Assoc       Date:  2020-11-23       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.